ArticleFrontiers in immunology2022

GluR3B Antibody Was a Biomarker for Drug-Resistant Epilepsy in Patients With Focal to Bilateral Tonic-Clonic Seizures.

Qingwei Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.